References
1
Weber L.
Curr. Med. Chem.
2002,
9:
1241
2
Bienayme H.
Hulme C.
Oddon G.
Schmidt P.
Chem.-Eur. J.
2000,
6:
3321
3
Dömling A.
Ugi I.
Angew. Chem. Int. Ed.
2000,
39:
3168
4a
Ugi I.
Steinbrückner C.
Chem. Ber.
1961,
94:
734
4b
Ugi I.
Dömling A.
Hörl W.
Endeavour
1994,
18:
115
5
Lee D.
Sello JK.
Schreiber SL.
Org. Lett.
2000,
2:
709
6
Zhu J.
Eur. J. Org. Chem.
2003,
1133
7
Orru RVA.
de Greef M.
Synthesis
2003,
1471
8
Keating TA.
Armstrong RW.
J. Am. Chem. Soc.
1996,
118:
2574
9a
Strocker AM.
Keating TA.
Tempest PA.
Armstrong RW.
Tetrahedron Lett.
1996,
37:
1149
9b
Mjalli AMM.
Sarshar S.
Baiga TJ.
Tetrahedron Lett.
1996,
37:
2943
10
Short KM.
Mjalli AMM.
Tetrahedron Lett.
1997,
38:
359
11a
Chucholowski A.
Masquelin T.
Obrecht D.
Stadlwieser J.
Villalgordo JM.
Chimia
1996,
50:
525
11b
Hulme C.
Morrissette MM.
Volz FA.
Burns CJ.
Tetrahedron Lett.
1998,
39:
1113
12a
Brimble MA.
Johnston AD.
Tetrahedron
1994,
50:
4887
12b inventors; , CAN 68:49650 CIBA Ltd., US 3503980.
12c
Tatsuta K.
Tsuchiya T.
Umezawa S.
Naganawa H.
Umezawa H.
J. Antibiot.
1972,
25:
674
12d
Rossen K.
Sager J.
DiMichele LM.
Tetrahedron Lett.
1997,
38:
3183 ; and references cited therein
13
Cheng J.-F.
Chen M.
Arrhenius T.
Nazdan A.
Tetrahedron Lett.
2002,
43:
6293
For chemistry using 3-dimethylamino-2-isocyano-acrylic acid methyl ester in heterocyclic synthesis, see:
14a
Lau H.
Schöllkopf U.
Liebigs Ann. Chem.
1982,
2093
14b
Heck S.
Dömling A.
Synlett
2000,
424
14c
Helal CJ.
Lucas JC.
Org. Lett.
2002,
23:
4133
14d
Bienayme H.
Bouzid K.
Tetrahedron Lett.
1998,
39:
2735
15
General Procedure: The aldehyde (1 mmol) and the amine (1 mmol) were dissolved or suspended in MeOH (3 mL). The mixture was allowed to stir for 10 min at r.t. After adding 10 mol% Yb(OTf)3 and isocyanide 4 (1 mmol) the reaction mixture was stirred at r.t. overnight. The solvent was evaporated. The resulting residue was purified by preparative HPLC.
16 Crystal structure analysis of compound 1a: C16H18N2O4,
M
r = 302.32; colorless fragment (0.18 × 0.30 × 0.56 mm3); triclinic, P-1(No.: 2), a = 7.2017(1), b = 7.8496(1), c = 14.1983(3) Å, α = 75.7470(6)°, β = 86.4000(6)°, γ = 74.6796(9)°, V = 750.28(2) Å3, Z = 2, d
calcd = 1.338 gcm-3; F(000) = 320; µ = 0.097 mm-1. A total of 17941 reflections were integrated and corrected for Lorentz and polarization effects. After merging (R
int = 0.032), 2735 [2366: Io > 2σ(Io)] independent reflections remained and all were used to refine 271 parameters. All non-hydrogen atoms were refined with anisotropic displacement parameters. All hydrogen atoms were found and refined with individual isotropic displacement parameters. Full-matrix least-squares refinements were carried out by minimizing Σw (F
o
2 - F
c
2)
[2]
and converged with R1 = 0.0354 [Io > 2σ(Io)], wR2 = 0.0967 [all data], GOF = 1.067 and shift/error < 0.001. Crystallographic data (excluding structure factors) for the structure reported in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-220501(1a). Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44(1223)336033; e-mail: deposit@ccdc.cam.ac.uk]
17
General Procedure for Plate Synthesis: MeOH solution of the amine and aldehyde component (50 mL, 0.1 M) were dispensed on plate. Yb(OTf)3 (50 mL, 0.1 M) and MeOH solution of the Schöllkopf isocyanide 4 (50 mL, 0.1 M) were added. The plate was shaken overnight at r.t. and the solvent was evaporated. The crude reaction mixtures were prepared for LC-MS analytics (0.1 mM solution in MeOH-H2O = 1:1).
18 Spectral data for compound 1a: 1H NMR (400 MHz, DMSO-d
6): δ = 0.36-0.41 (m, 2 H, CH2), 0.44-0.52 (m, 2 H, CH2), 1.10-1.16 (m, 1 H, CH), 3.70 (s, 3 H, CH3), 3.73 (s, 3 H, CH3), 4.07 (d, 1 H, J = 7.8 Hz, CH), 6.93 (d, J = 9.14 Hz, 2 H, CHarom), 7.18 (d, J = 9.48 Hz, 2 H, CHarom), 7.24 (s, 1 H, CH=), 9.61(s, 1 H, NH). 13C NMR (100 MHz, DMSO-d
6):
δ = 2.24, 4.07, 12.10, 51.25, 55.22, 62.35, 107.18, 114.63, 119.46, 123.48, 136.66, 155.53, 161.49, 161.93. MS (ESI): m/z = 303.3 [M + H]+, 325.2 [M + Na]+.
Spectral data for compound 1f: 1H NMR (400 MHz, DMSO-d
6): δ = 1.20 (t, 2 H, CH2), 1.43-1.47 (m, 4 H, 2CH2), 1.61-1.71 (m, 2 H, CH2), 1.90-1.93 (m, 2 H, CH2), 3.61 (s, 3 H, CH3), 6.88 (s, 1 H, CH=), 7.20-7.24 (m, 2 H, 2CH), 7.31-7.35 (m, 2 H, 2CH), 9.32 (s, 1 H, NH). 13C NMR (100 MHz, DMSO-d
6): δ = 22.38, 24.62, 30.53, 51.07, 61.09, 105.29, 115.80, 116.03, 129.97, 131.63, 131.72, 138.50, 138.53, 159.80, 161.68, 163.75. MS (ESI): m/z = 319.0 [M + H]+, 341.0 [M + Na]+.
19 Illgen K, Fuchs T, and Nerdinger S. inventors; , CAN 138:401756 Int. Pat. Appl. WO03042187.